Creso Pharma Limited (ASX: CPH) (the ‘Company’) requests the voluntary suspension of all quoted securities of the Company, pending an announcement regarding a material sales and revenue update, as announced to ASX on 25 June 2021.
The Company requests that its securities remain in suspension until the release of the aforementioned announcement, which is expected to be lodged on or before Thursday, 1 July 2021.